Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCMA Launches Ad Campaign On Medicare Formulary Design

This article was originally published in The Pink Sheet Daily

Executive Summary

Print ad asks "Guess who's coming to dinner?" and features a sumo wrestler representing "the big drug companies." Inside-the-Beltway advertising campaign is designed to ensure that Medicare Rx formulary design permits current market practices, the PBM association says.

You may also be interested in...



Large Employers, Insurers, PCMA Ask CMS To Retain Formulary Tools

A group of large employers, insurance companies and the Pharmaceutical Care Management Association has sent a letter to the Centers for Medicare & Medicaid Services arguing that the Medicare drug benefit should permit a wide range of cost effectiveness tools

Large Employers, Insurers, PCMA Ask CMS To Retain Formulary Tools

A group of large employers, insurance companies and the Pharmaceutical Care Management Association has sent a letter to the Centers for Medicare & Medicaid Services arguing that the Medicare drug benefit should permit a wide range of cost effectiveness tools

Seniors Support Transparency For All Drug Pricing Agreements – PCMA Survey

More than three-quarters of seniors polled support disclosure by drug manufacturers of all types of pricing agreements, a survey sponsored by the Pharmaceutical Care Management Association indicates

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel